Michel van Gelder

3PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 10, 2024
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

Christof Scheid, Diderik-Jan Eikema, Michel van Gelder

|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.

Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis

|Dec 05, 2016
Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer.

Michel van Gelder, Ariane Vanclée, Catharina H M J van Elssen

Pageof 1